Discovery of DNA methylation markers in cervical cancer using relaxation ranking

Maté Ongenaert1, G Bea A Wisman, Haukeline H Volders

  • 1Laboratory for Bioinformatics and Computational Genomics (BioBix), Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Belgium. mate.ongenaert@ugent.be

BMC Medical Genomics
|November 26, 2008
PubMed
Abstract

Insights

A new ranking algorithm effectively identifies DNA methylation markers for cervical cancer by analyzing cell line and primary sample data. This method enriches for methylated genes, revealing potential biomarkers for early cancer detection.

Area of Science:

  • * Molecular Biology
  • * Cancer Genomics
  • * Bioinformatics

Background:

  • * Large-scale screening for cancer-specific DNA methylation markers is crucial.
  • * Pharmacological unmasking expression microarray enriches for silenced genes but often lacks relevance to primary cancers.
  • * Integrating primary cancer sample data with cell line data is essential for robust marker discovery.

Purpose of the Study:

  • * To develop and apply a novel relaxation ranking algorithm for identifying DNA methylation markers in cervical cancer.
  • * To improve the enrichment of candidate methylation markers by combining in vitro and in vivo data.
  • * To validate the algorithm's efficacy in identifying biologically relevant methylation markers.

Main Methods:

  • * Applied a new relaxation ranking algorithm to sort high-throughput microarray data from cervical cancer cell lines and primary samples.
  • * Performed in silico analysis to assess the sorting methodology's performance.
  • * Conducted pathway and gene ontology analysis on top-ranked genes.
  • * Experimentally verified the DNA methylation status of top-ranked candidate genes in cervical carcinomas and normal tissues.

Main Results:

  • * The ranking algorithm successfully sorted microarray data from both cell lines and primary cervical cancer samples.
  • * Pathway analysis indicated enrichment towards genes involved in cell cycle regulation, programmed cell death, and development.
  • * Verification revealed that 78% of the top 10 ranked gene promoters were methylated in cervical carcinomas, with 3 novel markers identified.
  • * Known methylation markers, including CCNA1, were highly ranked, supporting the algorithm's power.

Conclusions:

  • * The novel relaxation ranking methodology significantly enriches for cancer-associated methylation markers.
  • * The approach demonstrates efficacy both in silico and through experimental validation.
  • * Identified novel methylation markers show promise for early detection of cervical cancer.